Establishment of CD7+ Human Myeloma Sister Cell Lines, KMS-21-PE and KMS-21-BM, Carrying t(11;14) and t(8;14)

References

• Seto M., Yamamoto K., Iida S., Akao Y, Utsumi K. R., Kubonishi I., Miyoshi I., Ohtsuki T., Yawata Y., Namba M., Arnold A., TakahashiUeda T.R. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 1992; 7: 1401–146
   PubMed Web of Science ®Google Scholar
• Akiyama N., Tsuruta H., Sasaki H., Sakamoto H., Hamaguchi M., Ohmura Y., Seto M, Ueda R., Hirai Yazaki H.Y. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). Cancer Research 1994; 154: 377–379
   Google Scholar
• Ronchetti D., Finelli P., Richelda R., Baldini L., Rocchi M., Viggiano L., Cuneo A., Bogni S., Fabris S., Lombardi L., Maiolo A. T., Neri A. Molecular analysis of 11q13 breakpoints in multiple myeloma. Blood 1999; 93: 1330–1337
   PubMed Web of Science ®Google Scholar
• Hollis G. F., Gazdar A. F., Bertness V., Kirsch I. R. Complex translocation disrupts c-myc regulation in a human plasma cell myeloma. Molelucar and Cellular Biology 1988; 8: 124–129
   PubMed Web of Science ®Google Scholar
• Shou Y, Martelli M. L., Gabrea A., Qi Y., Brents L. A., Roschke A., Dewald G., Kirsch I. R., Bergsagel P. L., Kuehl W. M. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America 2000; 97: 228–233
   PubMed Web of Science ®Google Scholar
• Sole F., Woessner S., Acin P., Perez-Losada A., Florensa L., Besses Sans C., Sabrafen J. Burkitt's type translocation in multiple myeloma. Leukemia Research 1994; 18: 671–673
   PubMed Web of Science ®Google Scholar
• Chesi M., Nardini E., Brents L. A., Schrock E., Ried T., Kuehl W. M., Bergsagel P. L. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genetics 1997; 16: 260–264
   PubMed Web of Science ®Google Scholar
• Richelda R., Ronchetti D., Baldini L., Cro L., Viggiano L., Marzella R., Rocchi M., Otsuki T., Lombardi L., Maiolo A, Neri T.A. A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factorreceptor 3 gene. Blood 1997; 90: 4062–4070
   PubMed Web of Science ®Google Scholar
• Chesi M., Nardini E., Lim R. S., Smith K. D., Kuehl W. M., Bergsagel P. L. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSEThybrid transcripts. Blood 1998; 92: 3025–3034
   PubMed Web of Science ®Google Scholar
• Iida S., Rao P. H., Butler M., Corradini P., Boccadoro M., Klein B., Chaganti R. S., Dalla-Favera R. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nature Genetics 1997; 17: 226–230
   PubMed Web of Science ®Google Scholar
• Chesi M., Bergsagel P. L., Shonukan O. O., Martelli M. L., Brents L. A., Chen T., Schrock E., Ried T., Kuehl W. M. Frequent dysregulation of the c-maf proto-oncogeneat 16q23 by translocation to an Ig locus in multiple myeloma. Blood 1998; 91: 4457–4463
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Matsuo Y. Mlignant hematopoietic cell lines: in vivo models for the study of multiple myeloma and plasma cell leukemia. Leukemia Research 2000; 24: 681–703
   PubMed Web of Science ®Google Scholar
• Otsuki T., Yamada O., Yata K., Nakazawa N., Taniwaki M., Sakaguchi H., Yawata Ueki Y.A. Genetic and biological characterization of human myeloma cell lines: A review of the lines established at Kawasaki Medical School. Gene Function and Disease 2000; 1: 48–56
   Google Scholar
• Ohtsuki T., Yawata Y, Wada H., Sugihara T., Mori Namba M. M. Two human 1 myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). British Journal of Haematology 1989; 73: 199–204
   PubMed Web of Science ®Google Scholar
• Shirato L., Otsuki T., Yamada O., Namba M., Nakajima H., Nozawa Y., Ueki Yawata A. Y. Down regulation of protein kinase C during growth enhancement induced by interleukin-6 on a human myeloma cell line, KMS-11. Cancer Letters 1996; 107: 131–136
   PubMed Web of Science ®Google Scholar
• Otsuki T., Nakazawa N., Taniwaki M., Yamada O., Sakaguchi H., Wada H., Yawata Ueki Y. A. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-λ to BJP-λ, and associated with hyperammonemia. International Journal of Oncology 1998; 12: 545–552
   PubMed Web of Science ®Google Scholar
• Otsuki T., Yamada O., Sakaguchi H., Ichiki T., Kouguchi K., Wada H., Hata H., Yawata Y. A. Ueki. In vitro excess ammonia production in human myeloma cell lines. Leukemia 1998; 12: 1149–1158
   PubMed Web of Science ®Google Scholar
• Takashima T., Itoh M., Ueda Y., Nishida K., Tamaki T., Misawa S., Abe T., Seto M., Machii T., Taniwaki M. Detection of 14q32.33 translocation and t(11;14) in interphase nuclei of chronic B-cell leukemia/lymphomas by in situ hybridization. International Jpirnal of Cancer 1997; 72: 31–38
   PubMed Web of Science ®Google Scholar
• Yamamoto K., Hamaguchi H., Nagata K., Taniwaki M. A variant Burkitt-type translocation (8;22)(q24;q11) in multiple myeloma. Report of a new case and review of the literature. Cancer Genetics and Cytogenetics 1998; 104: 98–103
   PubMed Web of Science ®Google Scholar
• Diss T. C., Peng H., Wotherspoon A. C., Isaacson P. G., Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. Journal of Pathology 1993; 169: 291–295
   PubMed Web of Science ®Google Scholar
• Deane M., McCrathy K. P., Wiedemann L. M., Norton J. D. An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia, 5: 726–730
   PubMed Web of Science ®Google Scholar
• McCarthy K. P., Sloane J. P., Wiedemann L. M. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. Journal of Clinical Pathology 1990; 43: 429–432
   PubMed Web of Science ®Google Scholar
• McCarthy K. P., Sloane J. P., Kabarowski J. H., Matutes E., Wiedemann L. M. The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. American Journal of Pathology 1991; 138: 821–828
   PubMed Web of Science ®Google Scholar
• Kneba M., Bolz I., Linke B.W. Hiddemann. Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis. Blood 1995; 86: 3930–3937
   PubMed Web of Science ®Google Scholar
• van Dongen J. J., Quertermous T., Bartram C. R., Gold D. P., Wolvers-Tettero I. L., Comans-Bitter W. M., Hooijkaas H., Adriaansen H. J., de Klein Raghavachar A.A. T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level. Journal of Immunology 1987; 138: 1260–1269
   PubMed Web of Science ®Google Scholar
• Kurebayashi J., Otsuki T., Tang C. K., Kurosumi M., Yamamoto S., Tanaka K., Mochizuki M., Nakamura Sonoo H.H. Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6. British Journal of Cancer 1999; 79: 707–717
   PubMed Web of Science ®Google Scholar
• Otsuki T., Yamada O., Yata K., Sakaguchi H., Kurebayashi J., Nakazawa N., Taniwaki M., Yawata Ueki Y.A. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32.3) and FGFR3 translocation. International Journal of Oncology 1999; 15: 1205–1212
   PubMed Web of Science ®Google Scholar
• Ma Z., Otsuki T., Tomokuni A., Aikoh T., Matsuki T., Sakaguchi H., Isozaki Y., Hyodoh F., Uehira K., Isoda Ueki K.A. Man-made mineral fibers induce apoptosis of human peripheral blood mononuclear cells similarly to chrysotile B. International Journal of Molecular Medicine 1999; 4: 633–637
   PubMed Web of Science ®Google Scholar
• Otsuki T., Tomokuni A., Sakaguchi H., Aikoh T., Matsuki T., Isozaki Y., Hyodoh F., Kusaka M., Kita Ueki S.A. Overexpression of decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells derived from silicosis cases. Clinical and Experimental Immunology 2000; 119: 323–327
   PubMed Web of Science ®Google Scholar
• Lai J. L., Michaux L., Dastugue N., Vasseur F., Daudignon A., Facon T., Bauters Zandecki F.M. Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant. Cancer Genetics and Cytogenetics 1998; 104: 133–138
   PubMed Web of Science ®Google Scholar
• Avet-Loiseau H., Li J. Y., Facon T., Brigaudeau C., Morineau N., Maloisel F., Rapp M. J., Talmant P., Trimoreau F., Jaccard A., Harousseau J. L., Bataille R. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Research 1998; 58: 5640–5645
   PubMed Web of Science ®Google Scholar
• Pratt G., Fenton J. A., Proffitt J. A., Rawstron A. C., Davies F. E., Child J. A., Morgan G. J. True spectrum of 14q32 translocations in multiple myeloma. British Journal of Haematology 1998; 103: 1209–1210
   PubMed Web of Science ®Google Scholar
• Nishida K., Tamura A., Nakazawa N., Ueda Y., Abe T., Matsuda F., Kashima Taniwaki K.M. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 1997; 90: 526–534
   PubMed Web of Science ®Google Scholar
• Gabrea A., Bergsagel P. L., Chesi M., Shou Y., Kuehl W. M. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Molecular Cell 1999; 3: 119–123
   PubMed Web of Science ®Google Scholar
• Matsuzaki H., Uchiba M., Yoshimura K., Yoshida M., Akahoshi Y., Okazaki Takatsuki K.K. Hyperammonemia in multiple myeloma. Acta Haematologica 1990; 84: 130–134
   PubMed Web of Science ®Google Scholar
• Martinelli G., Peccatori F., Ullrich B., Ghielmini M., Roggero Goldhirsch E.A. Clinical manifestation of severe hyperammonaemia in patients with multiple myeloma. Annals of Oncology 1997; 8: 811
   PubMed Web of Science ®Google Scholar
• Keller DR., Keller K. Hyperammonemic encephalopathy in multiple myeloma. American Journal of Hematology 1998; 57: 264–265
   PubMed Web of Science ®Google Scholar
• Matsuzaki H., Hata H., Sonoki T., Matsuno F., Kuribayashi N., Yoshida M., Nagasaki A, Murata H., Fujiyama Takatsuki S.K. Serum amino acid disturbance in multiple myeloma with hyperammonemia. International Journal of Hematology 1995; 61: 131–137
   PubMed Web of Science ®Google Scholar
• Leo R., Boeker M., Peest D., Hein R., Bartl R., Gessner J. E., Selbach J., Wacker Deicher G.H. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells. Annals of Hematology 1992; 64: 132–139
   PubMed Web of Science ®Google Scholar
• Van Camp B., Durie B. G., Spier C., De Waele M., Van Riet I., Vela E., Frutiger Y., Richter L., Grogan T. M. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 1990; 76: 377–382
   PubMed Web of Science ®Google Scholar
• Van Riet I., De Waele M., Remels L., Lacor P., Van Schots R., Camp B. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. British Journal of Haematology 1991; 79: 421–427
   PubMed Web of Science ®Google Scholar
• Barker H. F., Hamilton M. S., Ball J., Drew M., Franklin I. M. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. British Journal of Haematology 1992; 81: 331–335
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles G. J., San Miguel J. F. Cell surface markers in multiple myeloma. Mayo Clinic Proceedings 1994; 69: 684–690
   PubMed Web of Science ®Google Scholar
• Garand R., Voisin S., Papin S., Praloran V., Lenormand B., Favre M., Philip P., Bernier M., Vanhaecke Falkenrodt D.A. Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucemies. Leukemia 1993; 7: 161–167
   PubMed Web of Science ®Google Scholar
• Hata H., Matsuzaki H., Sonoki T., Takemoto S., Kuribayashi N., Nagasaki Takatsuki A.K. Establishment of a CD45-positive immature plasma cell line from an aggressive multiple myeloma with high serum lactate dehydrogenase. Leukemia 1994; 8: 1768–1773
   PubMed Web of Science ®Google Scholar
• Janssen J. W.G., Vaandrager J-W., Heuser T., Jauch A., Kluin P. M., Geelen E., Bergsagel L. P., Kuehl M. W., Drexler H. G., Otsuki T., Bartram C. R., Schuuring E. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood 2000; 95: 2691–2698
   PubMed Web of Science ®Google Scholar
• Klein G. Immunoglobulin gene associated chromosomal translocations in B-cell derived tumors. Current Topics in Microbiology and Immunology 1999; 246: 161–167
   PubMed Web of Science ®Google Scholar